Table: OncoTherapy Science - 6-MTH group results

OncoTherapy Science

10/11/2023 08:00

Nov 10 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            356 mln             514 mln                    
                 (-30.7 pct)        (+113.9 pct)                  
  Operating     loss 694 mln        loss 618 mln                  
  Recurring     loss 708 mln        loss 643 mln                  
  Net           loss 710 mln        loss 613 mln                  
  EPS           loss 3.42 yen       loss 3.19 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T